Clinical Trial Update: A Randomized Controlled Trial on the Efficacy and Safety of Butylphthalide in Reducing Myocardial Infarction Size and Improving Outcomes in STEMI Patients After Primary PCI [Phase 3]

View source ↗

Summary

A Phase 3 randomized controlled trial is planned to evaluate the efficacy and safety of butylphthalide in reducing infarct size and improving outcomes in patien…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• St-segment Elevation Myocardial Infarction

Drugs mentioned

• Butylphthalide (butylphthalide)

Snippet

Sponsor: Xiangya Hospital of Central South University | Conditions: ST-segment Elevation Myocardial Infarction (STEMI) | Phase 3 | Status: NOT_YET_RECRUITING